Jagsonpal Pharmaceuticals Limited announced unaudited standalone earnings results for first quarter ended June 30, 2018. For the quarter, the company reported total income from operation were INR 424.04 million against total income from operation of INR 269.678 million a year ago. Profit before exceptional items & tax was INR 9.091 million against loss before exceptional items & tax of INR 42.207 million a year ago. Profit before tax was INR 9.091 million against loss before tax of INR 42.207 million a year ago. Net profit for the period was INR 7.273 million against net loss for the period of INR 42.207 million a year ago. Basic and diluted earnings per share was INR 0.28 against basic and diluted loss per share of INR 1.61 a year ago.